AU524925B2 - Antigenic modification of endogenous polypeptides - Google Patents

Antigenic modification of endogenous polypeptides

Info

Publication number
AU524925B2
AU524925B2 AU68695/74A AU6869574A AU524925B2 AU 524925 B2 AU524925 B2 AU 524925B2 AU 68695/74 A AU68695/74 A AU 68695/74A AU 6869574 A AU6869574 A AU 6869574A AU 524925 B2 AU524925 B2 AU 524925B2
Authority
AU
Australia
Prior art keywords
pro
antigen
polypeptide
ser
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU68695/74A
Other languages
English (en)
Other versions
AU6869574A (en
Inventor
C. Stevens Vernon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Ohio State University
Original Assignee
The Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Ohio State University filed Critical The Ohio State University
Publication of AU6869574A publication Critical patent/AU6869574A/en
Application granted granted Critical
Publication of AU524925B2 publication Critical patent/AU524925B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU68695/74A 1973-05-07 1974-05-07 Antigenic modification of endogenous polypeptides Expired AU524925B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
USUS357882 1973-05-07
US40682173A 1973-10-16 1973-10-16
USUS406821 1973-10-16

Publications (2)

Publication Number Publication Date
AU6869574A AU6869574A (en) 1975-11-13
AU524925B2 true AU524925B2 (en) 1982-10-14

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68695/74A Expired AU524925B2 (en) 1973-05-07 1974-05-07 Antigenic modification of endogenous polypeptides

Country Status (17)

Country Link
JP (1) JPS623128B2 (enExample)
AT (1) AT356263B (enExample)
AU (1) AU524925B2 (enExample)
CA (1) CA1057742A (enExample)
CH (1) CH622426A5 (enExample)
DD (1) DD113919A5 (enExample)
DE (1) DE2421943A1 (enExample)
FR (1) FR2228477B1 (enExample)
GB (1) GB1473601A (enExample)
HK (1) HK41280A (enExample)
IE (1) IE42002B1 (enExample)
IL (1) IL44779A (enExample)
MY (1) MY8100128A (enExample)
NL (1) NL7406098A (enExample)
NZ (1) NZ174192A (enExample)
PL (1) PL97318B1 (enExample)
SE (1) SE7406096L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594453B2 (en) * 1983-03-04 1990-03-08 Ohio State University, The Linear polymer polypeptides, process for their preparation, and vaccines containing them

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
FR2319379A1 (fr) * 1975-07-29 1977-02-25 All India Inst Medical Scie Vaccin contre la gravidite et procede de sa preparation
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (enExample) * 1976-09-16 1981-08-11
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 National Institute Of Immunology Birth control vaccine
FR2832066A1 (fr) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech Compositions vaccinales contraceptives comprenant un peptide ou un ensemble de peptides codes par tout ou partie de l'exon 1 d'un recepteur de la fsh

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (de) * 1963-07-17 1968-12-12 Behringwerke Ag Verfahren zur Herstellung von kuenstlichen Antigenen
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594453B2 (en) * 1983-03-04 1990-03-08 Ohio State University, The Linear polymer polypeptides, process for their preparation, and vaccines containing them

Also Published As

Publication number Publication date
DE2421943A1 (de) 1974-11-28
CH622426A5 (en) 1981-04-15
IL44779A0 (en) 1974-07-31
NL7406098A (enExample) 1974-11-11
FR2228477A1 (enExample) 1974-12-06
DE2421943C2 (enExample) 1989-10-26
FR2228477B1 (enExample) 1977-07-01
PL97318B1 (pl) 1978-02-28
IE42002L (en) 1974-11-07
NZ174192A (en) 1985-02-28
CA1057742A (en) 1979-07-03
GB1473601A (en) 1977-05-18
AT356263B (de) 1980-04-25
SE7406096L (sv) 1975-01-31
AU6869574A (en) 1975-11-13
DD113919A5 (de) 1975-07-05
ATA377074A (de) 1979-09-15
HK41280A (en) 1980-08-15
MY8100128A (en) 1981-12-31
IL44779A (en) 1977-10-31
IE42002B1 (en) 1980-05-21
JPS623128B2 (enExample) 1987-01-23
JPS5069221A (enExample) 1975-06-10

Similar Documents

Publication Publication Date Title
AU498757B2 (en) Cyclization of peptides
CA1028341A (en) Preparation of n-phosphono methyl glycine
CA1024130A (en) Ceramic materials
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
AU6869574A (en) Antigenic modification of endogenous polypeptides
CA1035792A (en) Preparation of 5-sec-alkyl-m-cresol
CA1029719A (en) Preparation of a-6-deoxy-5-hydroxytetracycline
AU508018B2 (en) Polypeptide cosmetic preparation
CA1026680A (en) Antiperspirant stick
AU472316B2 (en) Improvements inthe forming of materials
AU476488B2 (en) Preparation of 6-deoxytetracyclines
AU495192B2 (en) Dehydroformylation of acetoxybutyraldehydes
AU484974B2 (en) Preparation of aromatics
AU486481B2 (en) Preparation of methylcobalamine
CA1033741A (en) Derivatives of 4-hydroxy-5-azacoumarin
AU482566B2 (en) Preparation of glycol acetates
AU482894B2 (en) Novel polypeptides
AU479106B2 (en) Preparation of 2-amino-5-alkyl-1 thiadiazoles
AU490610B2 (en) Isolation of proteins
AU473503B2 (en) Antiseitic preparation
AU490829B2 (en) Polypeptides
AU484570B2 (en) Preparation of substituted diphenylnitroalkanes
CA1020945A (en) 2-benzimidazolethiol preparation
CA1020300A (en) Adducts of polypentenamers
CA1006393A (en) Curing of meats